clopidogrel and vitamin k semiquinone radical

clopidogrel has been researched along with vitamin k semiquinone radical in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (33.96)	29.6817
2010's	32 (60.38)	24.3611
2020's	3 (5.66)	2.80

Authors

Authors	Studies
Dörffler-Melly, J; Mahler, F; Schmidli, J	1
Devière, J; Hittelet, A	1
Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R	1
de Paola, AA; Veloso, HH	1
Berthold, HK; Müller-Oerlinghausen, B; Tiaden, JD; Wenzel, E	1
Steinbeck, G	1
Ezekowitz, M; Lee, R; Nagarakanti, R; Sodhi, S	1
Ansell, J; Becker, RC; Berger, PB; Douketis, JD; Dunn, AS; Jaffer, AK; Spyropoulos, AC	1
de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC	1
Chrolavicius, S; Connolly, SJ; Hart, RG; Hohnloser, SH; Pfeffer, M; Pogue, J; Yusuf, S	1
Go, AS	1
Crijns, HJ; Dinh, T; Pisters, R	1
Butaffuoco, F; Richard, T; Vanhaeverbeek, M	1
Goldstein, LB	1
Apostolakis, S; Lane, DA; Lip, GY; Shantsila, E	1
Grove, EL; Storey, RF	1
Abildstrom, SZ; Andersson, C; Gislason, GH; Hansen, ML; Hansen, PR; Hvelplund, A; Jørgensen, C; Køber, L; Madsen, JK; Sørensen, R; Torp-Pedersen, C	1
Lindhoff-Last, E; Tacke, J	1
Budaj, A; Chrolavicius, S; Connolly, SJ; De Caterina, R; Morais, J; Pogue, J; Renda, G; Yusuf, S	1
Schlitt, A	1
Alvarez-Contreras, L; Brugaletta, S; Cola, C; de Antonio, M; Ferreira-González, I; García-Picart, J; Martí, V; Martin-Yuste, V; Sabaté, M	1
Allison, PM; Bayat, M; Bracey, AW; Chen, AJ; Reyes, MA	1
Barroeta-Espar, I; Delgado-Mederos, R; Martí-Fàbregas, J; Mateo, J; Sáinz Pelayo, MP; Vidal-Jordana, A	1
Connolly, SJ; de Caterina, R; Eikelboom, JW; Hart, RG; Hirsh, J; Hohnloser, S; Ng, J; Pogue, J; Yusuf, S	1
Eckman, MH; Fang, MC; Go, AS; Halperin, JL; Howard, PA; Hughes, M; Hylek, EM; Lane, DA; Lip, GYH; Manning, WJ; Schulman, S; Singer, DE; Spencer, FA; You, JJ	1
De Smet, PA; Kramers, C; Lamfers, EJ; Pop, GA; Roukens, M; Warlé-Van Herwaarden, MF	1
Gislason, GH; Hansen, CM; Hansen, ML; Karasoy, D; Kristensen, SL; Køber, L; Lamberts, M; Olesen, JB; Ruwald, MH; Torp-Pedersen, C	1
Bergert, H; Bötticher, G; Gäbel, G; Saeger, HD; Weiss, N	1
Kastrati, A; Martischnig, A; Mayer, K; Mehilli, J; Sarafoff, N; Sibbing, D; Wealer, J	1
Apostolakis, S; Lip, GY; Shantsila, E	1
Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Lassen, JF; Lip, GY; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C	1
Airaksinen, KE; Biancari, F; Karjalainen, PP; Kirchhof, P; Kiviniemi, T; Laine, M; Lip, GY; Niemelä, M; Rubboli, A; Schlitt, A; Valencia, J; Vikman, S	1
Gislason, G; Sørensen, R	1
Thompson, PL; Verheugt, FW	1
Adriaenssens, T; Dewilde, WJ; Hansen, ML; Janssen, PW; Lamberts, M; Storey, RF; Ten Berg, JM; Verheugt, FW	1
Bode, C; Cohen, M; Fox, K; Gibson, CM; Halperin, J; Husted, S; Lip, GY; Mehran, R; Peterson, E; van Eickels, M; Verheugt, F; Wildgoose, P	1
Blann, AD; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F	1
Gaist, D; García Rodríguez, LA; Hallas, J; Pottegård, A; Poulsen, FR	1
Ajjan, RA; Angiolillo, DJ; Bass, TA; Bhatti, M; Cho, JR; DeGroat, C; Franchi, F; Guzman, LA; King, R; Phoenix, F; Rollini, F; Tello-Montoliu, A; Zenni, MM	1
Bordignon, S; Chun, JK; Dugo, D; Fürnkranz, A; Konstantinou, A; Perrotta, L; Schmidt, B	1
Gaist, D; García Rodríguez, LA; Hallas, J; Halle, B; Hellfritzsch, M; Pottegård, A; Poulsen, FR	1
Belmin, J; Jarzebowski, W; Lafuente-Lafuente, C; Melkonian, M; Pautas, E; Siguret, V	1
Berger, JS; Bjerring Olesen, J; Gerds, TA; Gislason, GH; Hansen, ML; Lamberts, M; Langtved Pallisgaard, J; Nissen Bonde, A; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C	1
Becher, PM; Blankenberg, S; Fluschnik, N; Schnabel, R; Westermann, D	1
Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N	1
Ben-Dor, I; Buchanan, KD; Gajanana, D; Iantorno, M; Okubagzi, PG; Pichard, AD; Rogers, T; Satler, LF; Thourani, VH; Torguson, R; Waksman, R; Weintraub, WS	1
Abdelrazek, S; Bömicke, T; Chafai, A; Eltaweel, S; Ferenc, M; Hochholzer, W; Neumann, FJ; Stratz, C; Trenk, D; Valina, C	1
Green, JB; Guimarães, PO; Holman, RR; Lokhnygina, Y; Lopes, RD; McGuire, DK; Peterson, ED; Stevens, SR	1
Chen, S; Gao, X; Ge, Z; Kong, X; Wang, F; Wang, Z; Zhang, J; Zuo, G	1
Darius, H	1
Adlbrecht, C; Cuhaj, C; Delle-Karth, G; Grabenwöger, M; Hasan, W; Mach, M; Poschner, T; Strouhal, A; Szalkiewicz, P; Watzal, V; Winkler, B	1
de Borst, GJ; Hannink, G; Kramers, K; Maas, DPMSM; Mees, BME; Reijnen, MMPJ; Riksen, NP; Ten Cate, H; van der Vijver-Coppen, RJ; Warlé, MC; Willems, LH; Zeebregts, CJ	1

Reviews

13 review(s) available for clopidogrel and vitamin k semiquinone radical

Article	Year
Management of anticoagulants before and after endoscopy. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Heparin; Heparin, Low-Molecular-Weight; Humans; Plasma; Postoperative Care; Preoperative Care; Ticlopidine; Vitamin K; Warfarin	2003
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, Volume: 126, Issue:3 Suppl Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Medicine; Extremities; Fibrinolytic Agents; Heparin; Humans; Intermittent Claudication; Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Tetrazoles; Thromboembolism; Ticlopidine; Vitamin K	2004
Chronic antithrombotic therapy in post-myocardial infarction patients. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombosis; Ticlopidine; Vitamin K; Warfarin	2008
[Medicinal therapy for interventional surgery of the peripheral vascular system]. Der Radiologe, 2010, Volume: 50, Issue:1 Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Therapy, Combination; Heparin; Humans; Infusions, Intravenous; Ischemia; Leg; Long-Term Care; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Thrombocytopenia; Thrombosis; Ticlopidine; Vitamin K	2010
[New aspects on "triple therapy" after coronary stent implantation]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:41 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk Factors; Stents; Stroke; Thrombosis; Ticlopidine; Vitamin K	2010
[Antithrombotic therapy after peripheral vascular treatment: what is evidence-based?]. Zentralblatt fur Chirurgie, 2012, Volume: 137, Issue:5 Topics: Aortic Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endarterectomy; Evidence-Based Medicine; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Humans; Iliac Artery; International Normalized Ratio; Peripheral Arterial Disease; Polyethylene Terephthalates; Polytetrafluoroethylene; Popliteal Artery; Postoperative Complications; Prosthesis Design; Ticlopidine; Veins; Vitamin K	2012
Pharmacokinetic considerations for antithrombotic therapies in stroke. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:10 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stroke; Tetrazoles; Thiophenes; Thrombin; Ticlopidine; Vitamin K	2013
Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Clinical therapeutics, 2014, Sep-01, Volume: 36, Issue:9 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Ticlopidine; Vitamin K; Warfarin	2014
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review. Journal of the American College of Cardiology, 2014, Sep-23, Volume: 64, Issue:12 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Ticlopidine; Vitamin K	2014
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis. Thrombosis and haemostasis, 2015, Volume: 114, Issue:2 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Humans; Mortality; Numbers Needed To Treat; Observational Studies as Topic; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Stroke; Thiazoles; Thrombophilia; Ticlopidine; Vitamin K	2015
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:7 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin	2017
Clinical Outcomes of Antithrombotic Strategies for Patients with Atrial Fibrillation After Percutaneous Coronary Intervention. International heart journal, 2019, May-30, Volume: 60, Issue:3 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Observational Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Vitamin K	2019
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis. Drugs, 2022, Volume: 82, Issue:12 Topics: Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Network Meta-Analysis; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Ticagrelor; Vitamin K	2022

Trials

7 trial(s) available for clopidogrel and vitamin k semiquinone radical

Article	Year
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. The New England journal of medicine, 2009, May-14, Volume: 360, Issue:20 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vascular Diseases; Vitamin K	2009
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W. European heart journal, 2010, Volume: 31, Issue:17 Topics: Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Irbesartan; Kaplan-Meier Estimate; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vitamin K	2010
Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Annals of internal medicine, 2011, Nov-01, Volume: 155, Issue:9 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sensitivity and Specificity; Stroke; Ticlopidine; Vitamin K	2011
One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. Clinical cardiology, 2014, Volume: 37, Issue:6 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Vessels; Female; Fibrinolytic Agents; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Ticlopidine; Vitamin K	2014
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention American heart journal, 2015, Volume: 169, Issue:4 Topics: Administration, Oral; Aged; Atrial Fibrillation; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Rivaroxaban; Thiophenes; Ticlopidine; Treatment Outcome; Vitamin K	2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study. Thrombosis and haemostasis, 2016, Volume: 115, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 Enzyme System; Dabigatran; Double-Blind Method; Electrodes; Female; Humans; Light; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thrombelastography; Thrombosis; Ticlopidine; Vitamin K	2016
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes. International journal of cardiology, 2019, 08-15, Volume: 289 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sitagliptin Phosphate; Stroke; Time Factors; Treatment Outcome; Vitamin K	2019

Other Studies

33 other study(ies) available for clopidogrel and vitamin k semiquinone radical

Article	Year
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1 Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Confidence Intervals; Dipyridamole; Drug Therapy, Combination; Embolectomy; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intermittent Claudication; Leg; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombectomy; Ticlopidine; Time Factors; Vitamin K	2003
Clopidogrel as antithrombotic therapy in atrial fibrillation. Chest, 2005, Volume: 128, Issue:1 Topics: Atrial Fibrillation; Atrial Flutter; Clopidogrel; Electric Countershock; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Vitamin K	2005
Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4 Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Anticoagulants; Aspirin; Association; Blood Cell Count; Cerebral Hemorrhage; Clopidogrel; Databases, Factual; Drug Information Services; Germany; Hemorrhage; Heparin; Humans; Phenprocoumon; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Thrombocytopenia; Ticlopidine; Time Factors; Treatment Outcome; Vitamin K	2005
[Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment]. MMW Fortschritte der Medizin, 2006, Apr-13, Volume: 148, Issue:15 Topics: Administration, Oral; Age Factors; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Germany; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Registries; Risk Factors; Thromboembolism; Ticlopidine; Vitamin K	2006
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, Volume: 133, Issue:6 Suppl Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Perioperative Care; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Ticlopidine; Treatment Outcome; Vitamin K	2008
Effect of oral antiplatelet agents on major bleeding in users of coumarins. Thrombosis and haemostasis, 2008, Volume: 100, Issue:6 Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K	2008
The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation. The New England journal of medicine, 2009, May-14, Volume: 360, Issue:20 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K	2009
Prevention of stroke in patients with atrial fibrillation. The Medical letter on drugs and therapeutics, 2009, Jun-01, Volume: 51, Issue:1313 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K; Warfarin	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vitamin K; Warfarin	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K	2009
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Thrombosis and haemostasis, 2009, Volume: 102, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Vitamin K; Warfarin	2009
The right oral antithrombotics in acute coronary syndromes. Lancet (London, England), 2009, Dec-12, Volume: 374, Issue:9706 Topics: Acute Coronary Syndrome; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine; Vitamin K	2009
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet (London, England), 2009, Dec-12, Volume: 374, Issue:9706 Topics: Adult; Aged; Aspirin; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Patient Admission; Proportional Hazards Models; Recurrence; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Vitamin K	2009
Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 6, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coated Materials, Biocompatible; Coronary Disease; Disease-Free Survival; Endothelial Cells; Female; Humans; Male; Platelet Aggregation Inhibitors; Stem Cells; Stents; Ticlopidine; Vitamin K	2011
How do we manage patients treated with antithrombotic therapy in the perioperative interval. Transfusion, 2011, Volume: 51, Issue:10 Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coagulants; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostasis, Surgical; Heparin; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Ticlopidine; Vitamin K; Warfarin	2011
[Intracerebral hemorrhage in anticoagulated patients: what do we do afterwards?]. Neurologia (Barcelona, Spain), 2012, Volume: 27, Issue:3 Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Female; Follow-Up Studies; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Risk; Risk Factors; Stroke; Ticlopidine; Vitamin K	2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, Volume: 141, Issue:2 Suppl Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Evidence-Based Medicine; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Risk Factors; Societies, Medical; Stroke; Ticlopidine; Vitamin K	2012
Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents. European journal of preventive cardiology, 2014, Volume: 21, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Attitude of Health Personnel; Clopidogrel; Community Pharmacy Services; Comorbidity; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Fibrinolytic Agents; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Hemorrhage; Humans; Male; Middle Aged; Netherlands; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; Ticlopidine; Vitamin K	2014
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation, 2012, Sep-04, Volume: 126, Issue:10 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stroke; Ticlopidine; Vitamin K	2012
Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. Journal of the American College of Cardiology, 2013, May-21, Volume: 61, Issue:20 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Patient Selection; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine; Vitamin K	2013
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation, 2014, Apr-15, Volume: 129, Issue:15 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Vitamin K; Warfarin	2014
Triple antithrombotic therapy: risky but sometimes necessary. Revista espanola de cardiologia (English ed.), 2014, Volume: 67, Issue:3 Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Vitamin K	2014
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark. Thrombosis and haemostasis, 2015, Volume: 114, Issue:5 Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Risk; Subarachnoid Hemorrhage; Thrombosis; Ticlopidine; Vitamin K	2015
Locked Away: Percutaneous Closure of a Malignant Left Atrial Appendage to Constrain an Unresolvable Thrombus. Circulation. Arrhythmia and electrophysiology, 2016, Volume: 9, Issue:8 Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Echocardiography, Transesophageal; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Septal Occluder Device; Thrombosis; Ticlopidine; Vitamin K	2016
Association of Antithrombotic Drug Use With Subdural Hematoma Risk. JAMA, 2017, Feb-28, Volume: 317, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Comorbidity; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hematoma, Subdural; Humans; Incidence; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Vitamin K; Young Adult	2017
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation. Heart (British Cardiac Society), 2018, Volume: 104, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome; Vitamin K	2018
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy? Herz, 2018, Volume: 43, Issue:1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Guideline Adherence; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Stents; Stroke; Thrombosis; Vitamin K	2018
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:3 Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K	2018
Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves. The American journal of cardiology, 2018, 11-01, Volume: 122, Issue:9 Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Vitamin K; Warfarin	2018
Pharmacodynamic safety of clopidogrel monotherapy in patients under oral anticoagulation with a vitamin K antagonist undergoing coronary stent implantation. Platelets, 2019, Volume: 30, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Clopidogrel; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stents; Vitamin K	2019
[Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:14 Topics: Acute Coronary Syndrome; Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Combined Modality Therapy; Cyclophosphamide; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stents; Stroke; Vitamin K	2020
The impact of antiplatelet and antithrombotic regimen after TAVI: Data from the VIenna CardioThOracic Aortic Valve RegistrY (VICTORY). European journal of clinical investigation, 2021, Volume: 51, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Aspirin; Austria; Clopidogrel; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Care; Registries; Survival Rate; Transcatheter Aortic Valve Replacement; Vitamin K	2021